|
|
cqconsult 8/5/2007 | 6 (2) | 2239 | 308 | 1 | English
Non Disclosure Agreement ... more>>
FDADocs 5/9/2008 | 0 (0) | 64 | 0 | 0 | English
NDA 50-710/S-017 and S-021 NDA 50-711/S-015 and S-017 Page 370-5179-00-1.1ZITHROMAX??(azithromycin tablets) and (azithromycin for oral suspension)DESCRIPTION ZITHROMAX?? (azithromycin ... more>>
anonymous 1/4/2008 | 0 (0) | 387 | 35 | 0 | English
??? 1 ??? COMPANY NAME [ADDRESS] [ADDRESS] _______________, 200_ CONFIDENTIAL Company /Person Name. [ADDRESS] [ADDRESS] Tel: Email: Attention: [NAME] Dear [NAME]: Confidentiality a... ... more>>
anonymous 4/14/2008 | 0 (0) | 140 | 5 | 0 | English
MUTUAL NON-DISCLOSURE AGREEMENT THIS AGREEMENT governs the disclosure of information by and between and as of Date"). 1. Definition of Confidential Information. As used herein, "Co... ... more>>
jasinhollis 9/5/2008 | 0 (0) | 109 | 3 | 0 | English
FDADocs 5/9/2008 | 0 (0) | 47 | 0 | 0 | English
NDA 20-406/S-057, NDA 21-281/S-014, and NDA 21-428/S-004 Page 3(Nos. 1541, 1543, 1544, 3046, 7309, 7311) TAPDN198-V1; Rev. Month, Year TAPDN198-V2; Rev. Month, YearPREVACID??(lansoprazole ... more>>
FDADocs 5/9/2008 | 0 (0) | 57 | 0 | 0 | English
NDA 50-710/S-023 NDA 50-711/S-019 NDA 50-784/S-007Page 3ZITHROMAX??(azithromycin tablets) and (azithromycin for oral suspension)To reduce the development of drug-resistant bacteria and ... more>>
FDADocs 5/9/2008 | 0 (0) | 38 | 0 | 0 | English
NDA 20-778/S-025 NDA 20-779/S-046 NDA 21-503/S-007 Page 3423-6004-00-7Agouron Pharmaceuticals, Inc. VIRACEPT?? Patient Prescribing Information [logo] VIRACEPT?? (nelfinavir mesylate) TABLETS ... more>>
FDADocs 5/9/2008 | 0 (0) | 46 | 0 | 0 | English
NDA 19-462/S-034 NDA 19-510/S-031 NDA 20-249/S-013 Page 13PEPCID??(FAMOTIDINE) INJECTION PREMIXED PEPCID?? (FAMOTIDINE) INJECTIONDESCRIPTION The active ingredient in PEPCID* (famotidine ... more>>
anonymous 6/15/2007 | 6.7 (24) | 22336 | 1859 | 5 | english
non-disclosure confidentiality forms ... more>>
mw 10/11/2007 | 0 (0) | 862 | 44 | 0 | English
Similar to an NDA, but for partnerships ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 32 | 0 | 0 | English
NDA 19-462/S-034 NDA 19-510/S-031 NDA 20-249/S-013 Page 13PEPCID??(FAMOTIDINE) INJECTION PREMIXED PEPCID?? (FAMOTIDINE) INJECTIONDESCRIPTION The active ingredient in PEPCID* (famotidine ... more>>
FDADocs 5/9/2008 | 0 (0) | 24 | 0 | 0 | English
NDA 20-154/S-050 NDA 20-155/S-039 NDA 20-156/S-040 NDA 21-183/S-016Patient InformationRx onlyVIDEX??(generic name = didanosine also known as ddI)VIDEX (didanosine) Pediatric Powder for ... more>>
mw 10/11/2007 | 8 (7) | 4207 | 410 | 2 | English
A free standard non-disclosure agreement geared for use at technology companies. ... more>>
FDADocs 5/8/2008 | 0 (0) | 27 | 0 | 0 | English
NDA 20-732 NDA 20-733 Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose.Information for PharmacistsSUBOXONE ... more>>
| | | |
| results / page 15/25/50 |
Page: 2 of 32
|
2...
|
|